ArticleEuroasian journal of hepato-gastroenterology
Predictors of Mortality in End-stage Renal Disease Patients Presenting with Upper Gastrointestinal Bleeding.
Article in Euroasian journal of hepato-gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Upper gastrointestinal bleeding (UGIB) is a life-threatening medical condition. Patients with end-stage renal disease (ESRD) are at an increased risk of bleeding and mortality. The etiology of UGIB in ESRD patients includes peptic ulcer disease, angiodysplasia, and the administration of anticoagulants. Therefore, we aimed to identify the factors predicting mortality in ESRD patients presenting with UGIB. Materials and methods: This prospective cohort study was carried out at the department of hepatogastroenterology, Sindh Institute of Urology and Transplantation (SIUT), from February 2022 to December 2023. For this study, 209 patients with ESRD on hemodialysis presenting with symptoms of NVUGIB were enrolled. Vital signs, laboratory parameters, and endoscopic findings were noted. The outcome was measured in terms of 1-month mortality. Univariate followed by multivariate logistic regression analysis was performed to identify the independent predictors of mortality in the ESRD population presenting with upper GI bleeding. Results: Out of 209 subjects, 92 died within 1 month. On multivariate analysis, diagnosis of diabetes was significant at Conclusion: This study has underlined that diabetes, hemodynamic instability, certain endoscopic findings, and the need for dual therapy are significant predictors of mortality in ESRD patients with UGIB. Aggressive management of such factors, if possible with early identification, significantly improves the outcome in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.